Patent · US Active

Crystallization method and bioavailability

US8399023B2 · kind B2 · utility

92Cited by

36References

28Claims

0Family size

Assignee

THAR PHARMACEUTICALS, INC. · US

Inventors

Mazen Hanna · Bradford, GB
Ning Shan · Tampa, US
Miranda L. Cheney · Tampa, US
David R. Weyna · Tampa, US
Raymond K. Houck · Oakmont, US

Key dates

Filing date	Jul 30, 2010
Grant date	Mar 19, 2013
Priority date	—
Expiry date	Jul 30, 2030

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07B2200/13
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Preparation, in-vitro and in vivo characterization of novel forms of (1-hydroxy-2-imidazol-1-yl-1-phosphono-ethyl)phosphonic acid, suitable for pharmaceutical compositions in drug delivery systems for humans.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.